Company Filing History:
1 out of 10 
1 out of 1 Years Active: 2004-2006
Title: Nathalie Faisant: Innovator in Biodegradable Microspheres for Cancer Treatment
Introduction
Nathalie Faisant is a prominent inventor based in Montreuil sur Marne, France. She has made significant contributions to the field of cancer treatment through her innovative work on biodegradable microspheres. With a total of 2 patents, her inventions focus on enhancing the efficacy of cancer therapies, particularly for glioblastoma.
Latest Patents
Faisant's latest patents involve the use of biodegradable microspheres that release a radiosensitizing anticancer agent. This invention is designed to produce a medicament that can be used simultaneously with, separately from, or spread over time with radiotherapy for treating glioblastoma. The use of these biodegradable microspheres has been shown to result in a patient survival time of at least 90 weeks, maintaining a therapeutically effective concentration in the parenchymatous area throughout this duration. The microspheres preferably contain 5-fluorouracil, administered via intratissular injection, while the radiotherapy targeting the tumorous mass is dosed at 60 Gy over approximately six weeks. Additionally, the invention includes a method for producing the biodegradable microspheres through emulsion-extraction, along with a suspension containing the microspheres obtained from this method.
Career Highlights
Throughout her career, Nathalie Faisant has worked with notable companies, including Laboratoires des Produits Éthiques Ethypharm. Her work in these organizations has contributed to her expertise in developing innovative solutions for cancer treatment.
Collaborations
Faisant has collaborated with esteemed colleagues such as Jean-Pierre Benoit and Philippe Menei, further enhancing her research and development efforts in the field of oncology.
Conclusion
Nathalie Faisant's contributions to the field of cancer treatment through her innovative use of biodegradable microspheres demonstrate her commitment to improving patient outcomes. Her work continues to pave the way for advancements in medical technology and cancer therapies.